Randomized controlled trial· 2019
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Kingsberg SA, Clayton AH, Portman D, et al.
Obstetrics & Gynecology
- PubMed
- 31599840
- Evidence level
- high
- Verification
- verified
Summary
Two phase 3 trials of bremelanotide in premenopausal women with HSDD.
Limitations
Population and indication were specific; results cannot be generalized to all libido concerns.